CrushSCI.com
提供学术论文选刊润色服务
BREAST CANCER RESEARCH AND TREATMENT 期刊封面 医学
返回期刊列表

Review Cycle Records

BREAST CANCER RESEARCH AND TREATMENT

Springer SCIE 非OA
2026新锐 3区2025中科院 3区2025 JCR Q2
119.1平均天数
115.5中位天数
27最短天数
191最长天数
2962025发文量

Paper Review Records

全部论文审稿周期

14 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

59 天

Real-world treatment patterns and clinical outcomes in patients with emerging estrogen receptor 1 (ESR1)-mutated ER+ metastatic breast cancer in the U.S., 2018-2024

作者Jane L. Meisel; Clara Chen; Ayush Kris; Meng Ru; Timothy Pham; James Roose

作者单位1. Department of Hematology and Medical Oncology, Emory Winship Cancer Institute, Emory University, Atlanta, USA; 2. AstraZeneca, Gaithersburg, USA; 3. Flatiron Health, New York, USA

PDF源文件 DOI 网页
103 天

Exploring trop-2-directed ADCs monotherapy and combination therapy in pretreated mTNBC: a real-world study

作者Jingze Liu; Linxiaoxiao Ding; Jiayi Wang; Tao Chen; Tianzhu Long; Qian Li; Jie Chai; Herui Yao; Ying Wang; Jianli Zhao

作者单位1. Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, P. R. China; 2. Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangzhou Regenerative Medicine and Health Guangdong Laboratory, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China; 3. Thyroid and Breast Surgery Department, Guangzhou Women and Children’s Medical center, Guangzhou Medical University, Guangzhou, China

PDF源文件 DOI 网页
119 天

Anthracycline-containing versus anthracycline-free carboplatin-based regimens in early-stage triple-negative breast cancer: real-world outcomes

作者Matthew R. Kroll; Mary C. Schroeder; Joan M. Neuner; Brahmendra R. Viyyuri; Aditya Ravindra; Dana McDougall; Cole G. Chapman; Nicole M. G. Fleege; Elizabeth A. Chrischilles; Xing Song; Sneha Phadke

作者单位1. Division of Hematology, Oncology, and Blood & Marrow Transplantation, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, USA; 2. Division of Health Services Research, Department of Pharmacy Practice and Science, University of Iowa College of Pharmacy, Iowa City, USA; 3. Division of General Internal Medicine, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, USA; 4. MercyOne Waterloo Hematology/Oncology, Waterloo, USA; 5. Department of Epidemiology, University of Iowa College of Public Health, Iowa City, USA; 6. Department of Biomedical Informatics, Biostatistics and Medical Epidemiology, University of Missouri School of Medicine, Columbia, USA

PDF源文件 DOI 网页
185 天

Real-world estrogen receptor alpha 1 ( ESR1 ) testing patterns and results for ER+/HER2- metastatic breast cancer in the United States, 2018–2024

作者Jane Meisel; Tim Pham; Clara Chen; Ayush Kris; James Roose

作者单位1. Department of Hematology and Medical Oncology, Emory Winship Cancer Institute, Emory University, Atlanta, GA, USA; 2. AstraZeneca, Gaithersburg, MD, USA; 3. Flatiron Health, New York, USA

PDF源文件 DOI 网页
99 天

Oestrogen receptor testing and initiation of adjuvant endocrine therapy in women with ductal carcinoma in situ: a population-based study

作者Qian Chen; Ian Campbell; Mark Elwood; Alana Cavadino; Phyu Sin Aye; Sandar Tin Tin

作者单位1. Department of Epidemiology and Biostatistics, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand; 2. Department of Surgery, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand; 3. Department of Pharmacology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand; 4. Division of Health, University of Waikato, Hamilton, New Zealand; 5. Cancer Epidemiology Unit, Oxford Population Health, University of Oxford, Oxford, UK

PDF源文件 DOI 网页
191 天

Associations of neighborhood deprivation with breast cancer tumor genomics, targeted treatment use, and survival

作者Emily L. Podany; Lorenzo Foffano; Lorenzo Gerratana; Arielle J. Medford; Natalie K. Heater; Eleonora Nicolò; Shaili Tapiavala; Letizia Pontolillo; Annika Putur; Diana A. Jaber; Katherine Clifton; Nitin Katakam; Sarah Addison; Marla Lipsyc-Sharf; Carolina Reduzzi; Foluso O. Ademuyiwa; Fabio Puglisi; William J. Gradishar; Cynthia X. Ma; Aditya Bardia; Massimo Cristofanilli; Andrew A. Davis

作者单位1. Department of Medicine, Washington University in St. Louis, St. Louis, USA; 2. Department of Medical Oncology, CRO Aviano, National Cancer Institute, IRCCS, Aviano, Italy; 3. Department of Medicine, University of Udine, Udine, Italy; 4. Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, USA; 5. Department of Medicine, Northwestern University, Chicago, USA; 6. Department of Medicine, Weill Cornell Medicine, New York, USA; 7. Medical Oncology, Department of Translational Medicine and Surgery, Universitá Cattolica del Sacro Cuore, Rome, Italy; 8. Department of Medicine, UCLA Health, Los Angeles, USA

PDF源文件 DOI 网页
93 天

Efficacy, safety, and biomarker analysis of neoadjuvant camrelizumab plus apatinib as a chemotherapy-free strategy for early-stage triple-negative breast cancer: a phase II study

作者Zhenluan Tian; Hengyu Li; Yuxin Deng; Herui Yao; Ying Wang; Liang Jin; Heran Deng; Na Chen; Jieqiong Liu

作者单位1. Department of Breast Tumour Centre, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China; 2. Guangdong Provincial Key Laboratory of Malignant Tumour Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China; 3. Department of Breast and Thyroid Surgery, Changhai Hospital, Navy Medical University (Second Military Medical University), Shanghai, China; 4. Department of Breast Surgery, Shenshan Medical Center, Memorial Hospital of Sun Yat-sen University, Shanwei, China

PDF源文件 DOI 网页
135 天

Body mass index-associated gut microbial taxa and functional pathways in women with benign and malignant breast disease

作者Jack W. Sample; Stephen Johnson; Tanya L. Hoskin; Matteo Redaelli; Marina R. Walther-Antonio; Jun Chen; Amy C. Degnim; Tina J. Hieken

作者单位1. Division of Breast and Melanoma Surgical Oncology, Department of Surgery, Mayo Clinic, Rochester, USA; 2. Department of Quantitative Health Sciences, Mayo Clinic, Rochester, USA; 3. Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, USA; 4. Mayo Clinic Comprehensive Cancer Center, Rochester, USA

PDF源文件 DOI 网页
140 天

Validation of a novel prognostic staging system for breast cancer incorporating age at diagnosis

作者Helen M. Johnson; Wenli Dong; Yu Shen; William Irish; Jan H. Wong; Nasreen A. Vohra; Nina Tamirisa

作者单位1. Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA; 2. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, USA; 3. Department of Surgery, Brody School of Medicine at East Carolina University, Greenville, USA

PDF源文件 DOI 网页
27 天

When immunotherapy hurts: neoadjuvant PD-1 inhibitors increase opioid use after mastectomy with reconstruction

作者Tyler P. Shern; Victoria Chamberlain; Logan R. Holt; Michele A. Gadd; Francys C. Verdial; Tolga Ozmen; Michelle C. Specht; Charles S. Dai; Barbara L. Smith

作者单位1. Division of Breast Surgery, Mass General Brigham, Boston, USA; 2. Division of Hematology Oncology, Mass General Brigham Cancer Institute, Boston, USA

PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿96.4 天

中位数77 天

Contact CrushSCI

联系 CrushSCI

扫码添加微信,或留下手机号/微信号,我们将与你确认稿件阶段、编辑需求和投稿计划。

当前选择:论文编辑服务

也可以预留联系方式

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。